Established in 1989, Otsuka America Pharmaceutical, Inc. (OAPI) is the part of the Otsuka Group (Otsuka) that oversees all pharmaceutical and medical device commercial activities in North America.
With an emphasis on neuroscience, oncology, cardio-renal, and medical device markets, OAPI has a proven record of successfully commercializing Otsuka-developed and in-licensed products, including products from Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). To learn more about OAPI’s marketed products, click here.
We are not the largest company in the industry, but our goal is to be the most highly regarded. We want to be known for bringing the best value possible to our customers through our clinical expertise, market knowledge, and understanding of clinical practice. To that end, we seek to be a magnet for talent, a place where the best employees choose to further their careers.
OAPI transforms the ability of our workforce to communicate more effectively through technology and helps each individual achieve higher aspirations through personal development. Structured to empower our people with the freedom to discover new and better ways to serve the healthcare community, we are poised to continue the amazing growth OAPI has experienced in recent years through new product launches and additional alliances.